"We focus on the whole patient at the Multiple Sclerosis and Neuroimmunology Clinic at UT Southwestern Medical Center. Our multidisciplinary team cares for patients with multiple sclerosis, transverse myelitis, neuromyelitis optica, optic neuritis, acute disseminated encephalomyelitis, and autoimmune encephalitis."

During the past decade, Multiple Sclerosis Treatment Center of Dallas conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Multiple Sclerosis Treatment Center of Dallas" are "Neuromyelitis Optica" (2 trials) and "Neuromyelitis Optica Spectrum Disorder" (2 trials). Many other conditions were trialed in "Multiple Sclerosis Treatment Center of Dallas" in a lesser frequency.

Most popular intervention types in "Multiple Sclerosis Treatment Center of Dallas" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eculizumab" (1 trials), "Placebo" (1 trials) and "eculizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Multiple Sclerosis Treatment Center of Dallas" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Multiple Sclerosis Treatment Center of Dallas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Multiple Sclerosis Treatment Center of Dallas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Multiple Sclerosis Treatment Center of Dallas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".